Canada vs Sweden: Treatment success rate for patients treated for MDR-TB
Canada
87.0%
in 2014
Sweden
87.0%
in 2022
Canada rank
27th
Sweden rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Canada
- Sweden
How they compare
Canada currently reports 87.0% against 87.0% in Sweden, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2003 it was Sweden ahead.
Canada ranks 27th and Sweden ranks 27th of 163 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.6% | 84.6% | 29.0% | Sweden |
| 2010s | 79.4% | 84.2% | 4.8% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Canada or Sweden?
- Canada, at 87.0% against 87.0% in Sweden as of 2014.
- What is the difference in treatment success rate for patients treated for mdr-tb between Canada and Sweden?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Sweden?
- 10 years are reported by both, from 2003 to 2014.
- How do Canada and Sweden rank globally for treatment success rate for patients treated for mdr-tb?
- Canada ranks 27th and Sweden ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.